Bank of America
CLPT icon

Bank of America’s ClearPoint Neuro CLPT Stock Holding History

Bank of America’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$601K Buy
66,075
+17,990
+37% +$227K ﹤0.01% 4802
2025
Q4 		$658K Buy
48,085
+4,958
+11% +$91.9K ﹤0.01% 4761
2025
Q3 		$940K Sell
43,127
-70,571
-62% -$831K ﹤0.01% 5367
2025
Q2 		$1.36M Buy
113,698
+86,304
+315% +$1.09M ﹤0.01% 5083
2025
Q1 		$326K Sell
27,394
-14,913
-35% -$232K ﹤0.01% 5895
2024
Q4 		$651K Buy
42,307
+28,742
+212% +$372K ﹤0.01% 5350
2024
Q3 		$152K Sell
13,565
-3,879
-22% -$37.1K ﹤0.01% 6150
2024
Q2 		$94K Buy
17,444
+5,082
+41% +$29.4K ﹤0.01% 6271
2024
Q1 		$84.1K Sell
12,362
-23,382
-65% -$163K ﹤0.01% 6321
2023
Q4 		$243K Buy
35,744
+17,260
+93% +$97.7K ﹤0.01% 5969
2023
Q3 		$92.6K Buy
18,484
+8,259
+81% +$49.1K ﹤0.01% 6275
2023
Q2 		$74K Sell
10,225
-5,866
-36% -$49.9K ﹤0.01% 6323
2023
Q1 		$136K Buy
16,091
+11,937
+287% +$105K ﹤0.01% 6124
2022
Q4 		$35.2K Sell
4,154
-964
-19% -$9.14K ﹤0.01% 6582
2022
Q3 		$53K Sell
5,118
-2,048
-29% -$27K ﹤0.01% 6649
2022
Q2 		$94K Sell
7,166
-8,748
-55% -$89.4K ﹤0.01% 6513
2022
Q1 		$166K Sell
15,914
-10,248
-39% -$93.3K ﹤0.01% 6574
2021
Q4 		$294K Buy
26,162
+16,804
+180% +$252K ﹤0.01% 6256
2021
Q3 		$166K Buy
9,358
+401
+4% +$7.52K ﹤0.01% 6425
2021
Q2 		$171K Buy
8,957
+4,690
+110% +$90.6K ﹤0.01% 6198
2021
Q1 		$90K Buy
4,267
+1,017
+31% +$21.8K ﹤0.01% 6435
2020
Q4 		$52K Sell
3,250
-221
-6% -$1.98K ﹤0.01% 6311
2020
Q3 		$19K Buy
3,471
+15
+0.4% +$66 ﹤0.01% 6292
2020
Q2 		$12K Buy
3,456
+186
+6% +$692 ﹤0.01% 6383
2020
Q1 		$12K Sell
3,270
-47,480
-94% -$233K ﹤0.01% 6306
2019
Q4 		$244K Hold
50,750
– – ﹤0.01% 5499
2019
Q3 		$257K Buy
+50,750
New +$208K ﹤0.01% 5508

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank of America's CLPT Position: Q1 2026 in Review

Bank of America increased its ClearPoint Neuro (CLPT) stake by 37% in Q1 2026, buying an estimated $227K and bringing the position to 66,075 shares worth $601K. The position accounts for ﹤0.01% of the portfolio, ranked #4802.

Bank of America first reported a position in CLPT in Q3 2019 and has held it in 27 quarters since. The position peaked at $1.36M in Q2 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Bank of America held 66,075 shares of ClearPoint Neuro worth $601K as of Q1 2026.
  • Bank of America bought 17,990 ClearPoint Neuro shares in Q1 2026, an estimated $227K.
  • ClearPoint Neuro made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4802 holding.
  • Bank of America first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 27 quarters since.
  • Bank of America's ClearPoint Neuro position peaked at $1.36M in Q2 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.